ARCHIVES

NCI Relates FDA Instructions On Latest IND Delays

This article is from The Cancer Letter archive.

Vol. 02 No. 44 | October 29, 1976

Download PDF Visit The Full Archive

Related Articles

In Brief: Jane Henney Sworn In As FDA Commissioner; Six Centers Retain Comprehensive Status

December 18, 1998

Eight Centers Picked To Host Regional Breast Cancer Summits

January 31, 1992

Nurses Must Assist In Pain Management, ONS Says

May 31, 1991

Roche Reports New Avastin Results As FDA Mulls Breast Cancer Indication.

February 15, 2008

Evidence Reported That Silica Increase Risk Of Cancer

September 7, 1984

Talactoferrin Second-Line Therapy Increases Survival In Stage IIIB/IV

October 28, 2011